Interviews

Lucinda Maine, PhD, RPh, the executive vice president and CEO of the American Association of Colleges of Pharmacy (AACP), describes the primary goals of AACP for the upcoming year.

Lucinda Maine, PhD, RPh, the executive vice president and CEO of the American Association of Colleges of Pharmacy (AACP), describes the mission and purpose of AACP.

Josh Stein, CEO and co-founder of AdhereTech, discusses how technology can enhance the ability of specialty pharmacies to manage their patients' therapy regimen.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses the cost implications of pricey cholesterol-lowering PCSK9 inhibitors.

Rinku A. Patel, PharmD, RPh, founder and CEO of KloudScript, discusses the optimal use of technology and data to improve patient care in specialty pharmacies.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of the CSI Specialty Group, discusses improved communication among specialty drug manufacturers and health care providers.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses the use of technology to improve patient care in specialty pharmacy.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses some of the obstacles pharmacists face in providing naloxone.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses the role of the pharmacist in monitoring opioid use.

Linda Spooner, PharmD, RPh, BCPS, FASHP, professor of pharmacy practice at MCPHS University, discusses ways health-system pharmacists can assist HIV patients who have just been admitted.

Josh Stein, CEO and Co-founder of AdhereTech, discusses how smart pill technology can improve adherence in patients on a specialty drug regimen.

Melanie Dodd, PharmD, PhC, BCPS, discusses the benefits of fiber supplements for patients managing chronic diseases.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, lists some factors that may contribute to the likelihood of a patient with diabetes needing to be readmitted.

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, outlines how pharmacists can optimize their role in creating hospital discharge plans for diabetes patients.

Jeff Goad, PharmD, MPH, details what pharmacists should know about traveler's diarrhea.

Katie Traylor, a PGY2 pharmacy resident in ambulatory care and family medicine, outlines the major glucose monitoring counseling points pharmacists can offer to patients prior to discharge.

Jeff Goad, PharmD, MPH, discusses the benefits of Pepto-Bismol for traveler's diarrhea.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, describes the major glucose monitoring counseling points pharmacists should offer to patients prior to discharge.

Jeff Goad, PharmD, MPH, discusses OTC heartburn relief for travelers.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, describes how certain blood glucose monitors are designed to cater to certain health populations.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the elements of an effective interdisciplinary collaborative patient management program.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses initiatives to optimize medication adherence.

Grant E. Knowles, vice president of business development at Ardon Health, discusses how biosimilars may impact the high cost of specialty drugs.

Marc O'Connor, chief operating officer of Curant Health, discusses how the transition to value-based care can be optimized for specialty stakeholders.

Gregory R. Morris, chief commercial officer at VirMedica, discusses how eAccess can benefit patients and providers.

Deborah Michaelson, MS, RPh, discusses the elements of an ideal specialty pharmacy therapy management program.

Marc O'Connor, chief operating officer of Curant Health, discusses efficiency in specialty pharmacy relationships.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, provides some key takeaways for pharmacists on atrial fibrillation management.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about patient-specific factors to consider when selecting a novel oral anticoagulant.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient's renal function and comorbidities affect dosing regimens for novel oral anticoagulants.